HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Vol 21, No 03, March 2017 – Get to Know TCM       » Chinese Scientists in Rice Breakthrough       » Leading Regional Medical Technology Trade Associations Reinforce their Commitment to Evidence-based Healthcare       » New Study Finds Extensive Use of Fluorinated Chemicals in Fast Food Wrap       » What Doesn't Kill You Makes You Stronger       » Life Under Pressure       » Understanding the Genetics of Human Height      
NEWS CRUNCH
Philip Morris International and British American Tobacco receive award from PETA science group for AOP developments

Neuchátel, Switzerland, and Southampton, UK, 6th February 2017 - Scientists from Philip Morris International (PMI) and British American Tobacco (BAT) have received an award from the PETA International Science Consortium Ltd for their contributions to the Adverse Outcome Pathway (AOP) Wiki, a publicly available knowledge base and online encyclopedia created by the European Commission's DG Joint Research Centre (JRC), the U.S. Environmental Protection Agency (EPA), and the Organization for Economic Co-operation and Development (OECD). BAT and PMI have developed two AOPs that map out the potential impact of substances on the circulatory system (hypertension) and on the respiratory system (decreased lung function) respectively and can be accessed at the AOP Wiki (https://aopkb.org/).

An AOP is a theoretical framework that describes a sequence of events and mechanisms by which substances, such as chemicals, can cause adverse human health effects. These frameworks can be used by scientists and regulators to predict adverse effects and protect human health using non-animal approaches.

"AOPs not only open the door to new approaches to toxicological assessment, they also allow for more timely and cost-effective testing that does not rely on long-term epidemiological studies", said Dr Karsta Luettich, Principal Scientist, PMI. "This will be of considerable benefit to research scientists, chemical and consumer product industries and also to regulatory bodies. PMI and BAT are committed to the '3Rs' strategy to replace, reduce and refine animal testing, and we hope that scientists in other fields and industries will utilize these AOPs in their own toxicological assessment work."

The award includes a financial prize that PMI and BAT have donated to PETA International Science Consortium to support ongoing AOP scientific activities. Dr Marianna Gaca, Pre-Clinical Assessment Manager, BAT, commented: "We are delighted that the PETA International Science Consortium have recognized our joint contribution to the AOP Wiki. This award recognizes the recent collaborative efforts made by BAT and PMI scientists to share knowledge, experiences and work together to help advance the field of non-animal testing supporting next-generation tobacco and nicotine product risk assessment."

"The AOPs that PMI and BAT have developed are highly significant in the context of 21st Century Toxicology," said Dr Amy Clippinger, Associate Director, PETA International Science Consortium. "Not only do they provide a framework for toxicological strategies that do not use animals, they also unlock the potential for deeper levels of scientific understanding than could be achieved with animal tests. The AOP Wiki - a collaborative effort between the OECD, the US Environmental Protection Agency and the European Commission's Joint Research Centre - is a vital resource in the modernization of toxicology. We greatly appreciate PMI and BAT's contributions to this important endeavor." Details of the award are available at http://www.piscltd.org.uk/aop-prize/.

For further information, please contact:

Mark Chamberlain
Advantage Integral
Mobile: +44 (0)7711 285 261
Email: mark@advantageintegral.com

Dr Marina Murphy
British American Tobacco
Tel: +44 (0)7711 150 135
Email : marina_murphy@bat.com

NEWS CRUNCH  
news Philip Morris International and British American Tobacco receive award from PETA science group for AOP developments
news 6th Asia-Pacific Breast Cancer Summit to take place in Hong Kong
news MIT Hacking Medicine Robotics in Singapore!
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2017
January:
Healthcare Focus: LUNGS
February:
War on CANCER
March:
Get to Know TCM
April:
Diabetics Technology
May:
The Piece of Your Mind - Brain Health/Science
June:
Women & Men's Health
July:
Food Science & Technology
August:
Eye Care/ Eye Health
September:
No. 1 Killer - Heart Diseases, Diagnosis and Treatment
October:
Skin Diseases/Allergic Reactions
November:
Diseases threatening our Children
December:
Liver Health & Treatment/Technology
Editorial calendar is subjected to changes.
– Editor: Carmen, Jia Wen Loh
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Carmen
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2017 World Scientific Publishing Co Pte Ltd  •  Privacy Policy